Delivery of nucleic acids into eukaryotic genomes using in vitro assembled mu transposition complexes
CA 2522438 C · Owner: Savilahti, Harri · Inventors: Paatero, Anja; Pajunen, Maria; Turakainen, Hilkka
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to genetic engineering and especially to the use of DNA transposition complex of bacteriophage Mu. In particular the invention , provides a gene transfer system for eukaryotic cells wherein in vitro , assembled Mu transposition complexes are introduced into a target cell and subsequently transposition into a cellular nucleic acid occurs. The invention further provides a kit for producing insertional mutations into the genomes of eukaryotic cells. The kit can be used, e.g. to generate insertional mutant libraries.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 14, 2004 and granted September 25, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 14, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 14, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.